2021
Checkpoint Inhibitor Colitis Shows Drug-Specific Differences in Immune Cell Reaction That Overlap With Inflammatory Bowel Disease and Predict Response to Colitis Therapy
Lo YC, Price C, Blenman K, Patil P, Zhang X, Robert ME. Checkpoint Inhibitor Colitis Shows Drug-Specific Differences in Immune Cell Reaction That Overlap With Inflammatory Bowel Disease and Predict Response to Colitis Therapy. American Journal Of Clinical Pathology 2021, 156: 214-228. PMID: 33555016, DOI: 10.1093/ajcp/aqaa217.Peer-Reviewed Original ResearchConceptsInflammatory bowel diseaseCD8/FOXP3 ratioBiopsy specimensCPI patientsPD-1CD68 scoreFOXP3 ratioBowel diseasePD-L1Antibody-treated patientsCheckpoint inhibitor colitisPD-L1 groupInitial biopsy specimensPD-L1 expressionImmune cell reactionsColonic biopsy specimensDrug-specific differencesIBD groupCheckpoint inhibitorsChronicity scoreActivity scoreImmune phenotypeTherapeutic responseColitisShared pathophysiology
1998
Effect of Heparin on Dextran Sulfate Sodium-Induced Colitis
Korzenik J, Hsu A, Robert M. Effect of Heparin on Dextran Sulfate Sodium-Induced Colitis. Digestive Diseases And Sciences 1998, 43: 1800-1805. PMID: 9724172, DOI: 10.1023/a:1018800207063.Peer-Reviewed Original ResearchConceptsBowel diseaseDextran Sulfate Sodium-Induced ColitisDextran sulfate-induced colitisSeverity of colitisSulfate-induced colitisInduction of colitisEffect of heparinMurine colitisSubcutaneous injectionWebster miceColitisHeparinized animalsHeparinAnticoagulant propertiesDiseaseMiceDextran sulfateOpposite effectSulfated polysaccharidesAnimalsDrinking waterSimilar pathwaysDosesSeverity